Accuray Incorporated (ARAY) is a Medical - Devices company in the Healthcare sector, currently trading at $0.40. It has a SharesGrow Score of 41/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is ARAY = $2 (+399.5% upside).
Valuation: ARAY trades at a trailing Price-to-Earnings (P/E) of -1.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.01.
Financials: revenue is $459M, +2.2%/yr average growth. Net income is $2M (loss), growing at -17.1%/yr. Net profit margin is -0.3% (negative). Gross margin is 32.1% (-5.1 pp trend).
Balance sheet: total debt is $176M against $81M equity (Debt-to-Equity (D/E) ratio 2.17, leveraged). Current ratio is 1.65 (strong liquidity). Debt-to-assets is 37.5%. Total assets: $470M.
Analyst outlook: 10 / 13 analysts rate ARAY as buy (77%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 30/100 (Fail), Past 0/100 (Fail), Health 33/100 (Fail), Moat 29/100 (Fail), Future 85/100 (Pass), Income 10/100 (Fail).
